Los Angeles Capital Management
VERA icon

Los Angeles Capital Management’s Vera Therapeutics VERA Stock Holding History

Los Angeles Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Buy
8,456
+7,544
+827% +$325K ﹤0.01% 986
2025
Q4 		$27.1K Buy
+912
New +$32.4K ﹤0.01% 1778

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Los Angeles Capital Management's VERA Position: Q1 2026 in Review

Los Angeles Capital Management increased its Vera Therapeutics (VERA) stake by 827% in Q1 2026, buying an estimated $325K and bringing the position to 8,456 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Los Angeles Capital Management first reported a position in VERA in Q4 2025 and has held it in 2 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Los Angeles Capital Management held 8,456 shares of Vera Therapeutics worth $340K as of Q1 2026.
  • Los Angeles Capital Management bought 7,544 Vera Therapeutics shares in Q1 2026, an estimated $325K.
  • Vera Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #986 holding.
  • Los Angeles Capital Management first reported a position in Vera Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.